The quest to understand why cellular cleanup systems fail with age has uncovered a surprising metabolic-genetic connection that could reshape approaches to neurodegeneration. Rather than simply providing energy, NAD+ appears to act as a molecular conductor orchestrating the precise assembly of cellular maintenance machinery.
Researchers examining worms, mice, and human brain samples discovered that NAD+ supplementation corrects hundreds of age-related RNA splicing errors—mistakes that accumulate as neurons age and contribute to protein buildup characteristic of Alzheimer's disease. The key player is EVA1C, a protein whose different molecular forms must be precisely balanced to maintain neuronal health. When NAD+ levels drop with aging, this balance shifts, compromising the cell's ability to clear damaged proteins through both autophagy and proteasomal degradation pathways.
The mechanism centers on EVA1C's interaction with molecular chaperones BAG1 and HSP70, forming a quality control network that tags misfolded proteins like tau for destruction. Without proper EVA1C isoform ratios, this system breaks down, allowing toxic protein aggregates to accumulate—a hallmark of neurodegenerative diseases.
This finding represents a significant advance in autophagy research, revealing that metabolic interventions can directly influence gene expression fidelity rather than simply boosting cellular energy. The cross-species validation strengthens the translational potential, though the complexity of the pathway suggests that timing, dosage, and individual genetic variations will likely influence therapeutic outcomes. The discovery positions NAD+ as both a metabolic cofactor and a transcriptional regulator, potentially explaining why some NAD+ interventions show variable results in human studies.
